KTOV the drug is a combo of 2 approved drugs,they need almost zero cash to go to the market.- “KIT-302 has the potential to address
the multi-billion dollar market for the treatment of osteoarthritis pain and hypertension with one drug that reduces patients’
risk of suffering a heart attack or stroke, while also reducing cost for payers. There is currently no single medication on the
market that treats both osteoarthritis
pain and hypertension and thus, KIT-302 will be the only NSAID indicated both to treat pain
and to reduce the risk of heart attack, stroke and death
could keep going after hours,imo
News 
Market Data 
Discover 
